{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:46:39Z","timestamp":1793969199004,"version":"4.8.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) and Multiple System Atrophy (MSA) are progressive and unremitting neurological diseases that are neuropathologically characterized by \u03b1-synuclein inclusions. Increasing evidence supports the aggregation of \u03b1-synuclein in specific brain areas early in the disease course, followed by the spreading of \u03b1-synuclein pathology to multiple brain regions. However, little is known about how the structure of \u03b1-synuclein fibrils influence its ability to seed endogenous \u03b1-synuclein in recipient cells. Here, we aggregated \u03b1-synuclein by seeding with homogenates of PD- and MSA-confirmed brain tissue, determined the resulting \u03b1-synuclein fibril structures by cryo-electron microscopy, and characterized their seeding potential in mouse primary oligodendroglial cultures. The combined analysis shows that the two patient material-amplified \u03b1-synuclein fibrils share a similar protofilament fold but differ in their inter-protofilament interface and their ability to recruit endogenous \u03b1-synuclein. Our study indicates that the quaternary structure of \u03b1-synuclein fibrils modulates the seeding of \u03b1-synuclein pathology inside recipient cells. It thus provides an important advance in the quest to understand the connection between the structure of \u03b1-synuclein fibrils, cellular seeding\/spreading, and ultimately the clinical manifestations of different synucleinopathies.<\/jats:p>","DOI":"10.1038\/s42003-022-03948-y","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T13:09:52Z","timestamp":1664543392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Quaternary structure of patient-homogenate amplified \u03b1-synuclein fibrils modulates seeding of endogenous \u03b1-synuclein"],"prefix":"10.1038","volume":"5","author":[{"given":"Benedikt","family":"Frieg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-0683","authenticated-orcid":false,"given":"James A.","family":"Geraets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Stroh\u00e4ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-5110","authenticated-orcid":false,"given":"Christian","family":"Dienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Mavroeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-0122","authenticated-orcid":false,"given":"Byung Chul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4707-933X","authenticated-orcid":false,"given":"Woojin S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Xilouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-6581","authenticated-orcid":false,"given":"Markus","family":"Zweckstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-5431","authenticated-orcid":false,"given":"Gunnar F.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"3948_CR1","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469\u20136473 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3948_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G. et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci. Lett. 251, 205\u2013208 (1998).","journal-title":"Neurosci. Lett."},{"key":"3948_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00441-017-2730-9","volume":"373","author":"A Recasens","year":"2018","unstructured":"Recasens, A., Ulusoy, A., Kahle, P. J., Di Monte, D. A. & Dehay, B. In vivo models of alpha-synuclein transmission and propagation. Cell Tissue Res. 373, 183\u2013193 (2018).","journal-title":"Cell Tissue Res."},{"key":"3948_CR4","doi-asserted-by":"publisher","first-page":"E4949","DOI":"10.1073\/pnas.1513426112","volume":"112","author":"AL Woerman","year":"2015","unstructured":"Woerman, A. L. et al. Propagation of prions causing synucleinopathies in cultured cells. Proc. Natl Acad. Sci. USA 112, E4949\u2013E4958 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3948_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng, C. et al. Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557, 558\u2013563 (2018).","journal-title":"Nature"},{"key":"3948_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Stroh\u00e4ker","year":"2019","unstructured":"Stroh\u00e4ker, T. et al. Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts. Nat. Commun. 10, 5535 (2019).","journal-title":"Nat. Commun."},{"key":"3948_CR7","doi-asserted-by":"crossref","unstructured":"De Giorgi, F. et al. Novel self-replicating alpha-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons. Sci. Adv. 6, eabc4364 (2020).","DOI":"10.1126\/sciadv.abc4364"},{"key":"3948_CR8","doi-asserted-by":"publisher","first-page":"e56825","DOI":"10.7554\/eLife.56825","volume":"9","author":"G Suzuki","year":"2020","unstructured":"Suzuki, G. et al. alpha-synuclein strains that cause distinct pathologies differentially inhibit proteasome. Elife 9, e56825 (2020).","journal-title":"Elife"},{"key":"3948_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00401-020-02163-5","volume":"142","author":"SAM Holec","year":"2021","unstructured":"Holec, S. A. M. & Woerman, A. L. Evidence of distinct alpha-synuclein strains underlying disease heterogeneity. Acta Neuropathol. 142, 73\u201386 (2021).","journal-title":"Acta Neuropathol."},{"key":"3948_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","volume":"139","author":"A Van der Perren","year":"2020","unstructured":"Van der Perren, A. et al. The structural differences between patient-derived alpha-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathol. 139, 977\u20131000 (2020).","journal-title":"Acta Neuropathol."},{"key":"3948_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41582-019-0306-x","volume":"16","author":"S Lempriere","year":"2020","unstructured":"Lempriere, S. alpha-Synuclein strains induce distinct diseases in mice. Nat. Rev. Neurol. 16, 66\u201366 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"3948_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau, A. et al. alpha-Synuclein strains target distinct brain regions and cell types. Nat. Neurosci. 23, 21\u201331 (2020).","journal-title":"Nat. Neurosci."},{"key":"3948_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser, M. et al. Structures of alpha-synuclein filaments from multiple system atrophy. Nature 585, 464\u2013469 (2020).","journal-title":"Nature"},{"key":"3948_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40478-019-0840-1","volume":"7","author":"T Klingstedt","year":"2019","unstructured":"Klingstedt, T. et al. Luminescent conjugated oligothiophenes distinguish between alpha-synuclein assemblies of Parkinson\u2019s disease and multiple system atrophy. Acta Neuropathol. Com. 7, 193 (2019).","journal-title":"Acta Neuropathol. Com."},{"key":"3948_CR15","doi-asserted-by":"publisher","first-page":"11897","DOI":"10.1074\/jbc.M113.542340","volume":"289","author":"ME Herva","year":"2014","unstructured":"Herva, M. E. et al. Anti-amyloid compounds inhibit alpha-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA). J. Biol. Chem. 289, 11897\u201311905 (2014).","journal-title":"J. Biol. Chem."},{"key":"3948_CR16","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nm1286","volume":"11","author":"J Castilla","year":"2005","unstructured":"Castilla, J., Saa, P. & Soto, C. Detection of prions in blood. Nat. Med. 11, 982\u2013985 (2005).","journal-title":"Nat. Med."},{"key":"3948_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz, M. et al. Development of a biochemical diagnosis of Parkinson disease by detection of alpha-Synuclein misfolded aggregates in cerebrospinal fluid. Jama Neurol. 74, 163\u2013172 (2017).","journal-title":"Jama Neurol."},{"key":"3948_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/2211-5463.13110","volume":"11","author":"S L\u00f6vestam","year":"2021","unstructured":"L\u00f6vestam, S. et al. Seeded assembly in vitro does not replicate the structures of alpha-synuclein filaments from multiple system atrophy. Febs Open. Bio. 11, 999\u20131013 (2021).","journal-title":"Febs Open. Bio"},{"key":"3948_CR19","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1073\/pnas.1917914117","volume":"117","author":"DR Boyer","year":"2020","unstructured":"Boyer, D. R. et al. The alpha-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure. Proc. Natl Acad. Sci. USA 117, 3592\u20133602 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3948_CR20","doi-asserted-by":"publisher","first-page":"e48907","DOI":"10.7554\/eLife.48907","volume":"8","author":"R Guerrero-Ferreira","year":"2019","unstructured":"Guerrero-Ferreira, R. et al. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. Elife 8, e48907 (2019).","journal-title":"Elife"},{"key":"3948_CR21","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert, M. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled amyloid-beta, tau, and alpha-synuclein. Science 349, 1255555 (2015).","journal-title":"Science"},{"key":"3948_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Masuda-Suzukake, M. & Falcon, B. Like prions: The propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 140, 266\u2013278 (2017).","journal-title":"Brain"},{"key":"3948_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset, L. et al. Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4, 2575 (2013).","journal-title":"Nat. Commun."},{"key":"3948_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts, W. et al. alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340\u2013344 (2015).","journal-title":"Nature"},{"key":"3948_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio, G. P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810\u2013813 (2001).","journal-title":"Nature"},{"key":"3948_CR26","doi-asserted-by":"publisher","first-page":"35245","DOI":"10.1074\/jbc.M603964200","volume":"281","author":"P Saa","year":"2006","unstructured":"Saa, P., Castilla, J. & Soto, C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 281, 35245\u201335252 (2006).","journal-title":"J. Biol. Chem."},{"key":"3948_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fnins.2019.00552","volume":"13","author":"J Ma","year":"2019","unstructured":"Ma, J., Gao, J., Wang, J. & Xie, A. Prion-like mechanisms in Parkinson\u2019s disease. Front. Neurosci.-Switz. 13, 552 (2019).","journal-title":"Front. Neurosci.-Switz."},{"key":"3948_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","volume":"373","author":"JA Steiner","year":"2018","unstructured":"Steiner, J. A., Quansah, E. & Brundin, P. The concept of alpha-synuclein as a prion-like protein: ten years after. Cell Tissue Res. 373, 161\u2013173 (2018).","journal-title":"Cell Tissue Res."},{"key":"3948_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","volume":"51","author":"HJ Lee","year":"2019","unstructured":"Lee, H. J., Ricarte, D., Ortiz, D. & Lee, S. J. Models of multiple system atrophy. Exp. Mol. Med. 51, 1\u201310 (2019).","journal-title":"Exp. Mol. Med."},{"key":"3948_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/glia.20909","volume":"58","author":"A Lehotzky","year":"2010","unstructured":"Lehotzky, A. et al. Tubulin polymerization-rpomoting protein (TPPP\/p25) is critical for oligodendrocyte differentiation. Glia 58, 157\u2013168 (2010).","journal-title":"Glia"},{"key":"3948_CR31","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S1353-8020(08)70483-8","volume":"13","author":"YJC Song","year":"2007","unstructured":"Song, Y. J. C. et al. p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Parkinsonism Relat. D. 13, S63\u2013S63 (2007).","journal-title":"Parkinsonism Relat. D."},{"key":"3948_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nbd.2004.06.006","volume":"17","author":"GG Kovacs","year":"2004","unstructured":"Kovacs, G. G. et al. Natively unfolded tubulin polymerization promoting protein TPPP\/p25 is a common marker of alpha-synucleinopathies. Neurobiol. Dis. 17, 155\u2013162 (2004).","journal-title":"Neurobiol. Dis."},{"key":"3948_CR33","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1074\/jbc.M410409200","volume":"280","author":"E Lindersson","year":"2005","unstructured":"Lindersson, E. et al. Pp25\/alpha stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J. Biol. Chem. 280, 5703\u20135715 (2005).","journal-title":"J. Biol. Chem."},{"key":"3948_CR34","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.bbadis.2015.09.012","volume":"1852","author":"S Szunyogh","year":"2015","unstructured":"Szunyogh, S., Olah, J., Szenasi, T., Szabo, A. & Ovadi, J. Targeting the interface of the pathological complex of alpha-synuclein and TPPP\/p25. Bba-Mol. Basis Dis. 1852, 2653\u20132661 (2015).","journal-title":"Bba-Mol. Basis Dis."},{"key":"3948_CR35","doi-asserted-by":"crossref","unstructured":"Ferreira, N. et al. Multiple system atrophy-associated oligodendroglial protein p25 alpha stimulates formation of novel alpha-synuclein strain with enhanced neurodegenerative potential. Acta Neuropathol. 142, 87\u2013115 (2021).","DOI":"10.1007\/s00401-021-02316-0"},{"key":"3948_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.conb.2020.01.014","volume":"61","author":"R Guerrero-Ferreira","year":"2020","unstructured":"Guerrero-Ferreira, R., Kovacik, L., Ni, D. C. & Stahlberg, H. New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy. Curr. Opin. Neurobiol. 61, 89\u201395 (2020).","journal-title":"Curr. Opin. Neurobiol."},{"key":"3948_CR37","first-page":"16","volume":"920","author":"MG Spillantini","year":"2000","unstructured":"Spillantini, M. G. & Goedert, M. The alpha-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Mol. Basis Dement. 920, 16\u201327 (2000).","journal-title":"Mol. Basis Dement."},{"key":"3948_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/B978-0-12-802395-2.00024-9","volume":"145","author":"I Alafuzoff","year":"2017","unstructured":"Alafuzoff, I. & Hartikainen, P. Alpha-synucleinopathies. Handb. Clin. Neurol. 145, 339\u2013353 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"3948_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.semcdb.2020.07.016","volume":"112","author":"L Montani","year":"2021","unstructured":"Montani, L. Lipids in regulating oligodendrocyte structure and function. Semin. Cell Dev. Biol. 112, 114\u2013122 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"3948_CR40","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/cells9040812","volume":"9","author":"Y Poitelon","year":"2020","unstructured":"Poitelon, Y., Kopec, A. M. & Belin, S. Myelin fat facts: an overview of lipids and fatty acid aetabolism. Cells-Basel 9, 812 (2020).","journal-title":"Cells-Basel"},{"key":"3948_CR41","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1471-4159.1973.tb07520.x","volume":"21","author":"WT Norton","year":"1973","unstructured":"Norton, W. T. & Poduslo, S. E. Myelination in rat-brain: changes in myelin composition during brain maturation. J. Neurochem. 21, 759\u2013773 (1973).","journal-title":"J. Neurochem."},{"key":"3948_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1471-4159.1967.tb09532.x","volume":"14","author":"JS O\u2019Brien","year":"1967","unstructured":"O\u2019Brien, J. S., Sampson, E. L. & Stern, M. B. Lipid composition of myelin from the peripheral nervous system. Intradural spinal roots. J. Neurochem. 14, 357\u2013365 (1967).","journal-title":"J. Neurochem."},{"key":"3948_CR43","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson, W. S., Jonas, A., Clayton, D. F. & George, J. M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443\u20139449 (1998).","journal-title":"J. Biol. Chem."},{"key":"3948_CR44","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1016\/j.febslet.2008.10.001","volume":"582","author":"H Karube","year":"2008","unstructured":"Karube, H. et al. N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules. FEBS Lett. 582, 3693\u20133700 (2008).","journal-title":"FEBS Lett."},{"key":"3948_CR45","doi-asserted-by":"publisher","first-page":"34328","DOI":"10.1074\/jbc.M004345200","volume":"275","author":"EJ Jo","year":"2000","unstructured":"Jo, E. J., McLaurin, J., Yip, C. M., St George-Hyslop, P. & Fraser, P. E. alpha-synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275, 34328\u201334334 (2000).","journal-title":"J. Biol. Chem."},{"key":"3948_CR46","doi-asserted-by":"publisher","first-page":"e2012171118","DOI":"10.1073\/pnas.2012171118","volume":"118","author":"P Kumari","year":"2021","unstructured":"Kumari, P. et al. Structural insights into alpha-synuclein monomer-fibril interactions. Proc. Natl Acad. Sci. USA 118, e2012171118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3948_CR47","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1039\/C8CC02204F","volume":"54","author":"M T\u00f6rnquist","year":"2018","unstructured":"T\u00f6rnquist, M. et al. Secondary nucleation in amyloid formation. Chem. Commun. 54, 8667\u20138684 (2018).","journal-title":"Chem. Commun."},{"key":"3948_CR48","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1021\/acschemneuro.9b00594","volume":"11","author":"A Peduzzo","year":"2020","unstructured":"Peduzzo, A., Linse, S. & Buell, A. K. The properties of alpha-synuclein secondary nuclei are dominated by the solution conditions rather than the seed fibril strain. ACS Chem. Neurosci. 11, 909\u2013918 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"3948_CR49","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1074\/jbc.M010907200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky, V. N., Li, J. & Fink, A. L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 276, 10737\u201310744 (2001).","journal-title":"J. Biol. Chem."},{"key":"3948_CR50","doi-asserted-by":"publisher","first-page":"e1207","DOI":"10.7717\/peerj.1207","volume":"3","author":"T Sneideris","year":"2015","unstructured":"Sneideris, T., Milto, K. & Smirnovas, V. Polymorphism of amyloid-like fibrils can be defined by the concentration of seeds. Peerj 3, e1207 (2015).","journal-title":"Peerj"},{"key":"3948_CR51","doi-asserted-by":"publisher","first-page":"669994","DOI":"10.3389\/fmolb.2021.669994","volume":"8","author":"S Hadi Alijanvand","year":"2021","unstructured":"Hadi Alijanvand, S., Peduzzo, A. & Buell, A. K. Secondary nucleation and the conservation of structural characteristics of amyloid fibril strains. Front. Mol. Biosci. 8, 669994 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"3948_CR52","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1021\/bi034938r","volume":"43","author":"LA Munishkina","year":"2004","unstructured":"Munishkina, L. A., Henriques, J., Uversky, V. N. & Fink, A. L. Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation. Biochemistry 43, 3289\u20133300 (2004).","journal-title":"Biochemistry"},{"key":"3948_CR53","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1021\/ja412105t","volume":"136","author":"S Campioni","year":"2014","unstructured":"Campioni, S. et al. The presence of an air-water interface affects formation and elongation of alpha-synuclein fibrils. J. Am. Chem. Soc. 136, 2866\u20132875 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"3948_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nchembio.1750","volume":"11","author":"C Galvagnion","year":"2015","unstructured":"Galvagnion, C. et al. Lipid vesicles trigger alpha-synuclein aggregation by stimulating primary nucleation. Nat. Chem. Biol. 11, 229\u2013U101 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"3948_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.1","volume":"49","author":"BC Jung","year":"2017","unstructured":"Jung, B. C. et al. Amplification of distinct alpha-synuclein fibril conformers through protein misfolding cyclic amplification. Exp. Mol. Med. 49, e314 (2017).","journal-title":"Exp. Mol. Med."},{"key":"3948_CR56","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00401-019-02014-y","volume":"138","author":"P Mavroeidi","year":"2019","unstructured":"Mavroeidi, P. et al. Endogenous oligodendroglial alpha-synuclein and TPPP\/p25 alpha orchestrate alpha-synuclein pathology in experimental multiple system atrophy models. Acta Neuropathol. 138, 415\u2013441 (2019).","journal-title":"Acta Neuropathol."},{"key":"3948_CR57","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Meth. 14, 331\u2013332 (2017).","journal-title":"Nat. Meth"},{"key":"3948_CR58","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"3948_CR59","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1107\/S2052252520000081","volume":"7","author":"J Zivanov","year":"2020","unstructured":"Zivanov, J., Nakane, T. & Scheres, S. H. W. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ 7, 253\u2013267 (2020).","journal-title":"IUCrJ"},{"key":"3948_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jsb.2017.02.003","volume":"198","author":"S He","year":"2017","unstructured":"He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163\u2013176 (2017).","journal-title":"J. Struct. Biol."},{"key":"3948_CR61","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s42003-019-0437-z","volume":"2","author":"T Wagner","year":"2019","unstructured":"Wagner, T. et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2, 218 (2019).","journal-title":"Commun. Biol."},{"key":"3948_CR62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","volume":"157","author":"G Tang","year":"2007","unstructured":"Tang, G. et al. EMAN2: An extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38\u201346 (2007).","journal-title":"J. Struct. Biol."},{"key":"3948_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pbiomolbio.2020.11.007","volume":"160","author":"KR Pothula","year":"2021","unstructured":"Pothula, K. R., Geraets, J. A., Ferber, I. I. & Schr\u00f6der, G. F. Clustering polymorphs of tau and IAPP fibrils with the CHEP algorithm. Prog. Biophys. Mol. Biol. 160, 16\u201325 (2021).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"3948_CR64","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ultramic.2018.12.009","volume":"203","author":"KR Pothula","year":"2019","unstructured":"Pothula, K. R., Smyrnova, D. & Schr\u00f6der, G. F. Clustering cryo-EM images of helical protein polymers for helical reconstructions. Ultramicroscopy 203, 132\u2013138 (2019).","journal-title":"Ultramicroscopy"},{"key":"3948_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jsb.2015.06.007","volume":"191","author":"M Spiegel","year":"2015","unstructured":"Spiegel, M., Duraisamy, A. K. & Schr\u00f6der, G. F. Improving the visualization of cryo-EM density reconstructions. J. Struct. Biol. 191, 207\u2013213 (2015).","journal-title":"J. Struct. Biol."},{"key":"3948_CR66","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D."},{"key":"3948_CR67","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D."},{"key":"3948_CR68","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1073\/pnas.181342398","volume":"98","author":"NA Baker","year":"2001","unstructured":"Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98, 10037\u201310041 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3948_CR69","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665\u2013W667 (2004).","journal-title":"Nucleic Acids Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03948-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03948-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03948-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T13:36:59Z","timestamp":1664545019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03948-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3948"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-03948-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"12 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author S.-J.L. declares the following competing interests: S.-J.L. is a founder and co-CEO of Neuramedy Co., Ltd. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1040"}}